Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin to Build CLIA-Approved DNA Testing Lab

NEW YORK, April 13 (GenomeWeb News) - Interleukin Genetics has signed a new lease that expands its Waltham, Mass.-based facilities from 6,000 to 19,000 square feet, the company said today.

Interleukin said it would use the new space to build a CLIA (Clinical Laboratory Improvement Act)-certified DNA laboratory to process DNA tests that it plans to launch next year.

In line with its expansion plans, Interleukin hired four new managers: Taha Keilani as medical director; Christopher Palatucci as senior director of business development and licensing; Paul Voegelin as director of operations and planning; and Gary Breton as DNA laboratory manager.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.